Publication

Morrison CM, Dial SM, Day WA, Joens LA. 2012. Investigations of Salmonella enterica serovar newport infections of oysters by using immunohistochemistry and knockout mutagenesis. Appl Environ Microbiol. 78:2867–73. doi:10.1128/AEM.07456-11.

Duan J, Mansour HM, Zhang Y, Deng X, Chen Y, Wang J, Pan Y, Zhao J. 2012. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm. 426:193–201. doi:10.1016/j.ijpharm.2012.01.020.

Roberge J, O’Rourke MK, Meza-Montenegro MM, Gutiérrez-Millán LE, Burgess JL, Harris RB. 2012. Binational arsenic exposure survey: methodology and estimated arsenic intake from drinking water and urinary arsenic concentrations. Int J Environ Res Public Health. 9:1051–67. doi:10.3390/ijerph9041051.

Byron SA, Min E, Thal TS, Tapia C, Hostetter G, Watanabe A, Azorsa D, Little TH and Kim S. (2012) Attenuation of NF-kappa B by the ING4 tumor suppressor in breast cancer. PLoS One 7(10):e46823. 2012.

Rausch MP, Hastings KT. 2012. GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. J Invest Dermatol. 132:154–62. doi:10.1038/jid.2011.236.

Lussier YA, Khodarev NN, Regan K, Corbin K, Li H, Ganai S, Khan SA, Gnerlich JL, Gnerlich J, Darga TE, et al. 2012. Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One. 7:e50141. doi:10.1371/journal.pone.0050141.

Acin S, Li Z, Mejia O, Roop DR, El-Naggar AK, Caulin C. 2011. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol. 225:479–89. doi:10.1002/path.2971.

Bolger TA, Wente SR. 2011. Gle1 is a multifunctional DEAD-box protein regulator that modulates Ded1 in translation initiation. J Biol Chem. 286:39750–9. doi:10.1074/jbc.M111.299321.

Ahluwalia MS, Patel M, Peereboom DM. 2011. Role of tyrosine kinase inhibitors in the management of high-grade gliomas. Expert Rev Anticancer Ther. 11:1739–48. doi:10.1586/era.11.166.

Zheng X, Cheung LS-L, Schroeder JA, Jiang L, Zohar Y, . 2011. A high-performance microsystem for isolating circulating tumor cells. Lab Chip. 11:3269–76. doi:10.1039/c1lc20331b.

Ooi A, Wong J-C, Petillo D, Roossien D, Perrier-Trudova V, Whitten D, Min BWH, Tan M-H, Zhang Z, Yang XJ, et al. 2011. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 20:511–23. doi:10.1016/j.ccr.2011.08.024.

Zheng X, Cheung LS-L, Schroeder JA, Jiang L, Zohar Y. 2011. Cell receptor and surface ligand density effects on dynamic states of adhering circulating tumor cells. Lab Chip. 11:3431–9. doi:10.1039/c1lc20455f.

Brabez N, Lynch RM, Xu L, Gillies RJ, Chassaing G, Lavielle S, Hruby VJ. 2011. Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment. J Med Chem. 54:7375–84. doi:10.1021/jm2009937.

Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T. 2011. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Mol Pain. 7:81. doi:10.1186/1744-8069-7-81.

Sheeran PS, Luois S, Dayton PA, Matsunaga TO. 2011. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir. 27:10412–20. doi:10.1021/la2013705.

Davis DM, Marcet JE, Frattini JC, Prather AD, Mateka JJL, Nfonsam VN. 2011. Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg. 213:352–61. doi:10.1016/j.jamcollsurg.2011.04.033.

Astorga B, Wunz TM, Morales M, Wright SH, Pelis RM. 2011. Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3). Am J Physiol Renal Physiol. 301:F378–86. doi:10.1152/ajprenal.00735.2010.

Stone J, Moskowitz GB. 2011. Non-conscious bias in medical decision making: what can be done to reduce it?. Med Educ. 45:768–76. doi:10.1111/j.1365-2923.2011.04026.x.

Badger TA, Segrin C, Figueredo AJ, Harrington J, Sheppard K, Passalacqua S, Pasvogel A, Bishop M. 2011. Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners. Qual Life Res. 20:833–44. doi:10.1007/s11136-010-9822-2.

Morrison CM, Armstrong AE, Evans S, Mild RM, Langdon CJ, Joens LA. 2011. Survival of Salmonella Newport in oysters. Int J Food Microbiol. 148:93–8. doi:10.1016/j.ijfoodmicro.2011.05.006.

Wright LE, Frye JB, Lukefahr AL, Marion SL, Hoyer PB, Besselsen DG, Funk JL. 2011. 4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats. Reprod Toxicol. 32:26–32. doi:10.1016/j.reprotox.2011.05.005.

Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O’Flatharta C, Foley MJ, Barrett HH, et al. 2011. Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells. 29:1149–57. doi:10.1002/stem.665.

Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA. 2011. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. Eur J Haematol. 87:37–45. doi:10.1111/j.1600-0609.2011.01615.x.

Cai M, Liu Z, Qu H, Fan H, Zheng Z, Hruby VJ. 2011. Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma. Eur J Pharmacol. 660:188–93. doi:10.1016/j.ejphar.2011.01.032.

McGregor HCJ, Gunderman RB. 2011. X-ray crystallography and the elucidation of the structure of DNA. AJR Am J Roentgenol. 196:W689–92. doi:10.2214/AJR.10.5479.